NGNE

NASDAQStock

Neurogene Inc.

$21.00-1.30 (-5.83%)

52-Week Range

$7.34

$34.37

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.69

Volume

194.4K

Avg Volume

276.9K

Performance

+31.18%

+10.07%

+27.79%

YTD

+10.62%

+33.53%

+47.68%

Price Chart

ETF Exposure

NGNE is held by 53 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VTI	Vanguard Total Stock Market ETF	0.00%	382,191	$6.7M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,529	$48K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	218	$4K	$1.29B	0.17%

PreviousPage 2 of 2

About NGNE ETF Exposure

Neurogene Inc. (NGNE) is held by 53 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $21.00. Investors can gain exposure to NGNE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NGNE, sorted by portfolio weight.